Your Business Partner

Ready for the wonderful HBA EMEA Circle of Advisors for Entrepreneurial Leaders. Happy and proud that our CEO and Founder Maria Rosaria Natale Ph.D. will share her story

Your Friday roundup is here! 🌟 Get ready to dive into this week’s key developments in pharma, healthtech, and automotive—everything you need to stay ahead is just a click away! 🚀   #PHARMA 👉 The Japanese company Otsuka Pharmaceutical Co., Ltd. is celebrating #50years of presence and activity in #Europe.   Learn more: https://lnkd.in/dsuJZTee   #AUTOMOTIVE 👉 Automobili Lamborghini S.p.A. sticks to its #electric plans: it will happen and it will be an addition.   Learn more: https://lnkd.in/dWg6kVCh   #HEALTHTECH 👉 Putting the #UK back on the map for clinical trials: NorthWest EHealth (NWEH) partners with Clinical Practice Research Datalink (CPRD).   Learn more: https://lnkd.in/ej4UxHq9

Thank you to Prof. Matteo G Della Porta, for sharing your vision for the future of hematology oncology care, with a special focus on Acute Myeloid Leukemia (AML) and their caregivers. A development in this area is the innovative oral pharmacological treatment that can be administered at the patient's home. This allows for an improved care pathway that maintains the same high hospital standards for monitoring and potential interventions, making treatment more accessible and convenient for patients. Humanitas Research Hospital #innovation #healthcare Otsuka Pharmaceutical Italy Srl #AML #AcuteMyeloidLeukemia

🚀 Kicking off this week's #PressReview with groundbreaking updates from the world of #Pharma, #HealthTech, and #Tech! Check out the latest innovations and partnerships shaping the future of healthcare and technology. #PHARMA 👉 Otsuka Pharmaceutical Co., Ltd. obtains exclusive global licensing rights from Ionis Pharmaceuticals, Inc. to #Ulefnersen, a potential treatment for #AmyotrophicLateralSclerosis caused by mutations in the Fused in Sarcoma Gene. Learn more: https://lnkd.in/dbFjPZPS #HEALTHTECH 👉 Università Bocconi, Humanitas Research Hospital, and Politecnico di Milano: #Teleconsultation for osteoporosis is effective, but only with the support of email. Learn more: https://lnkd.in/dhTMEcqg #TECH 👉 Vodafone's STEP road safety platform tested in Berlin. Learn more: https://lnkd.in/g3ktzbuc

Friday insights are here! 🎉 Wrap up the week with the latest news in pharma, healthtech, and tech—your essential press review is ready to keep you informed! 🌍💡 #PHARMA 👉 #RareDiseases: Laura Nocerino Laura N. Appointed New Rare BU Head of Takeda Italia. Learn more: https://lnkd.in/dFY_fvzJ #HEALTHTECH 👉 Humanitas Research Hospital: Two New #Technologies for #Research to Change the History of Cardiological, Neurological, and Oncological #Diseases. Learn more: https://lnkd.in/dNefFzNU #TECH 👉 Vodafone: How 'Business to Things' will transform #commerce. Learn more: https://lnkd.in/dJgVfPzU

Project "LIA" is an Otsuka Pharmaceutical Italy Srl sponsored project dedicated to individuals affected by #AML Acute Myeloid Leukemia. A huge thank you to the effective collaboration between the clinical team of hematology oncology, led by Prof. Matteo G Della Porta, and the Operations management team, led by Laura Di Dio , at Humanitas Research Hospital Rozzano. Your synergistic work enables the development of the best pharmacological, care, and monitoring pathways, with the goal of bringing treatment ever closer to patients. A real thank you to Dr. Marta Ubezio, Dr. Alessia Campagna , Dott. Alessandro Galimberti.

Start your week informed! 🚀 Dive into the latest insights shaping the future of healthcare, healthtech, and automotive with our press review—your essential Monday read! 🩺💡   #HEALTHCARE 👉 #Neurology: the new clinic opens at Humanitas Medical Care Lingotto.   Learn more: https://lnkd.in/d4q6_WFg   #HEALTHTECH 👉 NHS London: #drones deliver urgent blood samples for Guy's and St Thomas' NHS Foundation Trust.   Learn more: https://lnkd.in/dYAbbtzz   #AUTOMOTIVE 👉 AEHRA's Expansion Plans Presented to the Italian Ministry of Industry.   Learn more: https://lnkd.in/dyhXVCD9

Thank you, Chiara Maugeri, and thank you, Luca Damiani , for inviting us to be part of such an important day in your history. The Istituti Clinici Scientifici ICS Maugeri SpA Società Benefit stands as a remarkable institution built on a legacy of innovation, vision, and values that are more relevant than ever. Your commitment to occupational medicine, rehabilitation, particularly for the most vulnerable individuals, and your focus on supporting young people affected by substance dependencies, represent cutting-edge excellence and invaluable support for the entire Country. #innovation #occupational medicine, #rehabilitation, #substance dependencies

Ready for your weekly dose of insights? 📰💡 Here’s the latest press review on Italian Healthcare, Insurance, and Pharma — all the key updates you need to stay ahead as we head into the weekend!   #ITALIANHEALTHCARE 👉 Elizaveta Kon appointed Full Professor of #MusculoskeletalDiseases at Humanitas University, the first #woman in #Italy.   Learn more: https://lnkd.in/dVrif848   #INSURANCE 👉 Vittoria Assicurazioni S.p.A. inaugurates the #Skillab academy spaces.   Learn more: https://lnkd.in/d-GU6PCM   #PHARMA 👉 Lundbeck: Accelerated #growth for strategic brands (+21% CER) drives revenue up 13% CER in the first nine months of 2024.   Learn more: https://lnkd.in/dCn5Ts-9

Midweek insights from the world of #Automotive, #ItalianHealthcare and #Tech! 🚀 Check out the latest updates diving into the stories that matter today! 🌟👇   #AUTOMOTIVE 👉 #LamborghiniTemerario by Automobili Lamborghini S.p.A.: 13 unrivaled #driving experiences presented at #MontereyCarWeek 2024.   Learn more: https://lnkd.in/dKQTRxNY   #ITALIANHEALTHCARE 👉 #Type2Diabetes affects 6% of the Italian population: exercise and nutrition are key to managing the condition.   Learn more: https://lnkd.in/dmaK3piy   #TECH 👉 Vodafone Group announces Half Year 2025 Results.   Learn more: https://lnkd.in/e2_Zt2Ph